AdBlock Detected

Like so many things during this pandemic, COVID-19 rebound was a new aspect of response and care that required us to rapidly collect data and adequately respond. The Centers for…

Atea Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, has completed enrollment for its global phase 3 SUNRISE-3 trial, marking a significant step in developing bemnifosbuvir. This drug, an oral nucleotide polymerase…

In a traditional medical setting, when we think about the laboratory and diagnostic tests being conducted and we think about the clinic or hospital areas where patients are being cared…

Antimicrobial stewardship programs have become standard across hospitals in the United States in response to a 2014 recommendation from the Centers for Disease Control and Prevention (CDC).1 Although progress has…

The FDA has approved the first assay to screen blood donors for Malaria (Plasmodium). The approved product, the cobas Malaria test is manufactured by Roche and is designed to detect…

The entry of hepatitis B and D viruses (HBV/HDV) into cells is essential for initiating infection, involving the attachment of the preS1 viral surface protein to the hepatobiliary transporter known…

The Centers for Disease Control and Prevention (CDC) reports the US President’s Emergency Plan for AIDS Relief (PEPFAR) provides a course of tuberculosis preventive treatment (TPT) to all eligible clients…

PCR offers a faster alternative for pathogen identification, potentially improving patient outcomes. The rapid turnaround time for PCR results, particularly in detecting Clostridioides difficile (CDI), facilitates the timely initiation of…

The treatment of the hepatitis C virus (HCV) has evolved considerably in the past 15 years. Second-generation direct-acting antivirals entered the market in late 2014. Today we have well-tolerated, short-course…

In the COVID-19 pandemic, new variants have necessitated the adaptation of vaccines to maintain their efficacy. Moderna's mRNA-1273 vaccine, branded as SPIKEVAX, has been at the forefront of this battle,…